Navigation Links
VGI Announces the Launch of DISMISS Instruments for the VerteLoc™ Minimally Invasive Spine Stabilization System
Date:3/3/2009

VGI introduces a revolutionary surgical instrument system that is smaller in diameter than a pencil. The DISMISS® instrument system is designed specifically for the implantation of the VerteLoc™ Minimally Invasive Spine Stabilization System and will be unveiled at the Congress of Neurological Surgeons meeting in Phoenix, Arizona starting on March 12, 2009.

Winston-Salem, NC (PRWEB) March 3, 2009 -- VG Innovations, Inc. (VGI), announces the launch of a new surgical instrumentation system, named DISMISS®.

"DISMISS® stands for Directional Instrument System for Minimally Invasive Spine Surgery," stated VGI's President and CEO, Dan Grayson. "We have received very positive feedback from our surgeon users, regarding the biomechanical advantages of the VerteLoc™ Minimally Invasive Spine Stabilization system, so the next logical step was to further refine the system's current instrumentation. We have now taken minimally invasive spinal facet fusion to a whole new level with the DISMISS® instruments."

"The DISMISS® instruments, used specifically for the implantation of the VerteLoc™ implants, are smaller in diameter than a pencil," noted Executive Vice President and Chief Technical Officer Dr. Tov Vestgaarden. "In addition, we have not only reduced the size, but also the number of instruments required for surgical implantation. This is just the beginning of a whole new era in surgical instrumentation from VGI."

"New sets of the DISMISS® instruments will be distributed during the second and third quarters of 2009 to select VGI distributors throughout the United States," Grayson added. "These new instruments will allow our distributors to introduce the VerteLoc™ system
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

0

GOOD

Page: 1 2

Related biology technology :

1. AcroMetrix Announces the Release of OptiQuant-S Hepatitis C Virus (HCV) Panel
2. Morphotek(R), Inc. Announces Initiation of MORAb-009 Phase II Study in First- Line Treatment of Mesothelioma
3. CUREXO Technology Corporation Announces New Headquarters
4. Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities
5. Bionovo Announces Publication of Positive Phase 2 Trial Results for Menerba(TM)
6. Epistem Announces Research and Development Collaboration With a Major Pharmaceutical Company
7. Miami Beach Real Estate Attorney Announces Services to Assist Chinese and other International Real Estate Investors Purchase Discount Florida Homes
8. Sigma-Aldrich (NASDAQ:SIAL) Announces it Has Filed Its December 31, 2008 Form 10-K
9. Finesse Announces TruTorr(TM) Single-Use Pressure Sensor
10. Vasogen Announces 2008 Year-End Results
11. NOVAVAX Announces Preclinical Study Results for a Respiratory Syncytial Virus (RSV) Vaccine Candidate Directed Against the Fusion (F) Protein
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
VGI Announces the Launch of DISMISS Instruments for the VerteLoc™ Minimally Invasive Spine Stabilization System 
(Date:5/24/2013)... NJ (PRWEB) May 24, 2013 Dr. Ingrid ... NJ and Swedesboro, NJ, are proud to announce an Open ... will take place on Saturday, June 8th from 10 AM ... Warmuth, Anamaria Newport, MHS, PA-C and staff will be on ... fillers, laser and aesthetic treatments, and provide complimentary cosmetic consultations. ...
(Date:5/24/2013)... Senomyx , Inc. (NASDAQ: ... to discover, develop, and commercialize novel flavor ingredients, announced ... the Company,s Vice President, Biology and Gwen ... Communications, will present an overview of Senomyx,s technology and ... Time (7:25 a.m. Pacific Time) during the Citi 2013 ...
(Date:5/24/2013)... 24, 2013 Vestiage, Inc. (stock ... focused on science-based research and development, sales and ... and nutraceuticals, announced today that it is awarding ... the sale of Reluma Skin Illuminating Facial Care. ... application by sending an email to info(at)vestiageinc(dot)com and ...
(Date:5/23/2013)... Colo. , May 23, 2013 Venaxis, ... diagnostic company focused on obtaining FDA clearance and commercializing ... today announced the pricing of an underwritten public offering ... warrants to purchase 3,500,000 shares of its common stock ... a combined public offering price of $1.25 per share ...
Breaking Biology Technology:SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CITI 2013 GLOBAL CONSUMER CONFERENCE 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 3Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 5Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3
... markets, the trend in health care employment could be counted on ... bringing yearly growth up over 345,000.The MedZilla.com Employment Report analyzes the ... ... Seattle, WA (Vocus) December 3, 2008 -- The U.S. economy ...
... and HOUSTON, Dec. 2 Transgenomic,Inc. (OTC ... Inc. (OTC,Bulletin Board: PWRM) today announced that ... acquire exclusive rights for Power3 Medical,s Neurodegenerative,Biomarkers, ... Alzheimer,s,and Parkinson,s disease. Transgenomic plans to ...
... postmenopause , , MONTVALE, N.J., ... symptoms is a challenge for women experiencing menopause. OBG ... have recently published a supplement titled Vasomotor symptoms: Managing ... James McGregor, MD, CM and Lee P. Shulman, MD, discuss ...
Cached Biology Technology:The MedZilla Report: October 2008 Employment Outlook for Biotech/Pharma/Health 2The MedZilla Report: October 2008 Employment Outlook for Biotech/Pharma/Health 3Transgenomic Signs Letter of Intent for an Agreement to Exclusive License With Option to Acquire Power3 Medical Products' Neurodegenerative Diagnostics 2Transgenomic Signs Letter of Intent for an Agreement to Exclusive License With Option to Acquire Power3 Medical Products' Neurodegenerative Diagnostics 3Transgenomic Signs Letter of Intent for an Agreement to Exclusive License With Option to Acquire Power3 Medical Products' Neurodegenerative Diagnostics 4
(Date:5/24/2013)... noise in one French Quarter neighborhood of New Orleans ... ordinances, Annette Hurley, PhD, Assistant Professor of Audiology at ... a third-year LSUHSC doctor of audiology student, recommend that ... health. Their case study is published online in the ... ., "An important part of an audiologist,s practice is ...
(Date:5/23/2013)... honored more than 165 staff for their creation, ... annual Intellectual Property Commercialization Recognition & Rewards Program ... laboratory named materials scientist Jun Liu Inventor of ... that can store large amounts of energy, ease ... time it takes to charge cell phones, electric ...
(Date:5/23/2013)... the overall health, development, and academic success of ... ensuring that all students have opportunities to engage ... vigorous or moderate-intensity physical activity, says a new ... estimates suggest that only about half of school-age ... health and development. The report recommends that ...
Breaking Biology News(10 mins):Please do try this at home 2PNNL staff recognized for scientific accomplishments, moving technologies into the marketplace 2Schools should provide opportunities for 60 minutes of daily physical activity to all students 2Schools should provide opportunities for 60 minutes of daily physical activity to all students 3
... German . , In emerging countries such as ... consumption of red meat has quadrupled since 1961. The United ... lead to a doubling of global meat production by the ... limited farmland resources, will still be able to meet all ...
... DECEMBER 30, 2010 A recent study by a team ... incident of pathogens in biosolids over a 19 year period ... researchers also analyzed pathogen levels in biosolids at 18 wastewater ... analysis indicates pathogens levels have dropped since the implementation of ...
... you know that when you pick up a product promoted ... significant amount of this potentially harmful substance? An article by ... published in the January/February 2011 issue of the American ... can result in medically significant intake of harmful trans fat, ...
Cached Biology News:Eating low-fat, thanks to lupin proteins 2Wastewater treatment lowers pathogen levels 2Call for truth in trans fats labeling by the FDA 2
Immunogen: Peptide corresponding to amino acid residues from the N-terminal region of human thyroid hormone receptor, alpha1/alpha2-isotype. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Antibodies were affinity purified using epitopes specific to QKI immobilized on solid support....
Direct ELISA Assay Diluent, 10 L...
SpectroQuest single beam 1.8nm UV/Vis spectrophotometer; stand-alone unit...
Biology Products: